Variation in nursing home antipsychotic prescribing rates
Rochon PA, Stukel TA, Bronskill SE, Gomes T, Sykora K , Wodchis WP, Hillmer M, Kopp A, Gurwitz JH, Anderson GM. Arch Intern Med. 2007; 167(7):676-83.
Publications
Readers should systematically assess methods used to identify, measure and analyze confounding in observational cohort studies
Klein-Geltink JE, Rochon PA, Dyer S, Laxer M, Anderson GM. J Clin Epidemiol. 2007; 60(8):766-72. Epub 2007 Mar 26.
Antipsychotic use in older adults with Parkinson’s disease
Marras C, Kopp A, Qiu F, Lang AE, Sykora K, Shulman KI, Rochon PA. Mov Disord. 2007; 22(3):319-23.
Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?
Dhalla IA, Mamdani MM, Simor AE, Kopp A, Rochon PA, Juurlink DN. Antimicrob Agents Chemother. 2006; 50(9):3216-9.
Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement
Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C; CONSORT Group. Ann Intern Med. 2006; 144(5):364-7.
Cardiac valvulopathy associated with pergolide use
Zadikoff C, Rochon P, Lang A. Can J Neurol Sci. 2006; 33(1):27-33.
Mental health-related drug utilization among older adults: prevalence, trends, and costs
Mamdani M, Rapoport M, Shulman KI, Herrmann N, Rochon PA. Am J Geriatr Psychiatry. 2005; 13(10):892-900.
Atypical antipsychotics and parkinsonism
Rochon PA, Stukel TA, Sykora K, Gill S, Garfinkel S, Anderson GM, Normand SL, Mamdani M, Lee PE, Li P, Bronskill SE, Marras C, Gurwitz JH. Arch Intern Med. 2005; 165(16):1882-8.
Antipsychotic use in the elderly: shifting trends and increasing costs
Rapoport M, Mamdani M, Shulman KI, Herrmann N, Rochon PA. Int J Geriatr Psychiatry. 2005; 20(8):749-53.